WILL HEISE: Open Payments
NPI 1962840504 · CHOCTAW, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,028 in 57 payments from 10 companies in 2025. Trend: 2023 $565 · 2024 $384 · 2025 $1,028
Food & beverage: $1,028
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $285 |
| AstraZeneca Pharmaceuticals LP | 9 | $195 |
| Novo Nordisk Inc | 12 | $171 |
| Lilly USA, LLC | 8 | $152 |
| Lundbeck LLC | 2 | $56 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $52 |
| Exact Sciences Corporation | 3 | $46 |
| Amgen Inc. | 2 | $38 |
| PFIZER INC. | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: VRAYLAR, MOUNJARO, UBRELVY, AIRSUPRA, JARDIANCE, FARXIGA, Saxenda, REXULTI.
Industry payments across OK — which companies pay providers there.
